ExecPay

OncoGenex Pharmaceuticals

  • In Vitro and In Vivo Diagnostic Substances
  • Seattle, Washington

Compensation history

Top executives at OncoGenex Pharmaceuticals received an average of $771K per person in annual compensation from 2006 to 2022.

Average pay of disclosed executives at OncoGenex Pharmaceuticals

By year

Executives

We found 12 executives who work or worked at OncoGenex Pharmaceuticals.

John Bencich

OncoGenex Pharmaceuticals

Chief Executive Officer

9

Richard Stewart

OncoGenex Pharmaceuticals

Chairman

6

Cindy Jacobs

OncoGenex Pharmaceuticals

Chief Medical Officer

15

Anthony Clarke

OncoGenex Pharmaceuticals

Chief Scientific Officer

3

Scott Cormack

OncoGenex Pharmaceuticals

Chief Executive Officer

10

Susan Wyrick

OncoGenex Pharmaceuticals

Principal Accounting Officer and Vice President, Finance

2

Michelle Burris

OncoGenex Pharmaceuticals

Chief Financial Officer

3

Stephen Anderson

OncoGenex Pharmaceuticals

Chief Financial Officer

3

News

About OncoGenex Pharmaceuticals

  • Industry classifications
  • Division
    Manufacturing
    • Major group
      Chemicals And Allied Products
      • Industry group
        Drugs
        • Industry
          In Vitro and In Vivo Diagnostic Substances
  • Address
    22722 29th Dr. Se, Suite 100, Seattle, Washington 98021
  • Phone
    425-686-1500
  • Fiscal year end
    December 31
  • Former names
  • ONCOGENEX PHARMACEUTICALS, INC.
    Until July 30, 2017
  • SONUS PHARMACEUTICALS INC
    Until August 6, 2008
Source: SEC filings on April 28, 2023, April 21, 2022, March 30, 2021, April 2, 2020, March 28, 2019, April 19, 2018, September 21, 2017, April 24, 2014, April 21, 2011, April 19, 2010, and April 13, 2009.